Rebalix
Logo LGIMLGIM · sheet of 10 September 2026
ETF sheet · official issuer and register data

L&G Emerging Markets Corporate Bond (USD) Screened UCITS ETF EUR Hedged

EMMH · IE000ZO4CUT7 · class EUR Acc. Coperta · EUR · domicile Ireland
Bonds · Corporate USD · Emerging marketsEUR-hedged share classSFDR art. 8
Index tracked: J.P. Morgan ESG CEMBI Broad Diversified Custom Maturity Index
TER
0.38%+ trans. 0.00%
Fund size
194 m EUR
Tracking difference
not computable
🇮🇹 tax rate
white list not published
Replication
Physical (sampled)
Income
Accumulating
Duration
4.31 yrsmedium (3–7 years)
Launch 24 Aug 2021 · costs from the KID as of 2 Sept 2026 · 0 securities held · 1 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The investment objective of the Fund is to provide exposure to the US Dollar-denominated corporate bond market across emerging markets. The Fund is passively managed and aims to track the performance of the J.P. Morgan ESG CEMBI Broad Diversified Custom Maturity Index (the “Index”), before the deduction of fees and expenses. The Index is designed to provide exposure to U.S. dollar denominated emerging market corporate bonds, in accordance with its methodology. The Fund seeks to achieve its investment objective using an optimisation/representative…

Performance since series start (in euro) — base 100

20 Aug 202131 Jul 2026 · dividends reinvested where declared by the issuer
202220232024202520261007997
High 100 (13 Sept 2021) · low 79 (24 Oct 2022) · last 97. Past performance is not indicative of future results.

Returns in euro

1 year+2.1%
3 years+12.9%
5 years−3.1%
10 yearsseries too young
Since series start−3.1%

Risk · 1 / 3 / 5 years

Volatility (ann.)1.87%2.46%3.12%
Max drawdown−2.34%−2.77%−21.39%
Sharpe-0.790.53-0.98
Sortino-1.050.75-1.27
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · EMMH · IE000ZO4CUT71
RebalixEMMH · IE000ZO4CUT7 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: under review: anomalies in the fund or index series

Fixed income — as declared by the issuer

Factsheet · 30 Jun 2026
Maturity breakdown (% of fund)
0–5 years68.4%5–10 years20.3%10–15 years3.5%15–20 years2.7%20–25 years3.3%25–30 years1.5%30–40 years0.2%40+ years0.1%

Holdings

Portfolio as declared by the issuer · 30 Jun 2026 · 0 securities · top-10 weight = 4.4%
Countries (% of fund)
Emirati Arabi Uniti9.9%Cina9.2%Brasile8.6%Messico7.8%Arabia Saudita7.4%

Listing venues

ESMA register (FIRDS) and official exchange lists
EMMH · Borsa Italiana (ETFplus)
+ 6 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · fundcentres.landg.com/srp/documents-id/7e9c968f-3bbd-46c8-9968-f62fdaa
Factsheet · fundcentres.landg.com/srp/documents-id/b2fcf047-6734-4502-aa2e-ae8f924
Prospectus · fundcentres.landg.com/srp/lit/7qeQjP/Prospectus_Legal-General-UCITS-ET
The live sheet, always up to date
rebalix.com/en/etf/IE000ZO4CUT7
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · EMMH · IE000ZO4CUT72